Archive for July, 2010
LITT Nanoparticle Technology – New Cancer Treatment Shows Promise
A group of investigators at the Wake Forest Univ. Baptist Medical Center lately made an announcement that they have made noteworthy improvement in an investigational cancer treatment called LITT (laser-induced thermal therapy). The LITT treatment involves introduction of nanoparticles to the region surrounding the tumor after which laser treatment is employed for heating these nanoparticles and destroying the cancer-ridden tissues.
Study investigators from Wake Forest fine-tuned the therapy by employing iron-comprising MWCNTs (multi-walled carbon nanotubes – strands of hollow carbon which are ten thousand fold finer in comparison to a hair in humans) that could be traced inside the body of a patient via the usage of Magnetic resonance imaging (MRI), thus facilitating improved precision delivery [...]
July 26th, 2010 |
News
IMAT Treatment – Beneficial Technology for Paediatric Brain Cancer
A research presentation put forth during the fifty-second yearly conference of AAPM (Association of Physicists in Medicine) shows that kids with brain cancer undergoing radiation therapy (X-ray beams focused for killing malignant cells and shrivelling tumors) might be benefited by a technology termed as ‘IMAT’ or intensity modulated arc therapy.
Intensity modulated arc therapy method is reliant on novel attributes of the newest generation of X-ray treatment device which provide X ray sources in continually rotating varied directions encircling the patient at the time of therapy. This technique helps to increase directions from which the X-ray beams are coming from.
The research that was carried out by physical scientists from the St. Jude Children’s Hospital located in Memphis Tennessee [...]
July 21st, 2010 |
Brain Cancer, News
Nun’s Syndrome and Breast Cancer Epidemic
Annual sky-rocketing breast cancer cases continue to be a matter of grave concern in spite of periodical declarations of promising novel drugs and therapies. Just ten years back, a female’s lifetime risk of getting breast cancer was 1in twelve, however currently it has become 1 in 9.
Particularly bothersome are Britain’s statistics wherein breast cancer constitutes one-third of female’s cancers and afflicted over forty-seven thousand females during 2007.
Even though wide-ranging breast cancer causes exist, but it has become apparent that current lifestyles that women has adopted is accountable.
The most hyped exemplar is Kylie Minogue being identified with breast cancer in thirty-six. New-fangled studies in the United States have shown that breast tumors are arising (6 years sooner) among [...]
July 19th, 2010 |
Breast Cancer, News
Novel Treatments and Medications for Aggressive, Slow-Spreading Lymphomas
For several decades, non-Hodgkin’s lymphoma (NHL) research has remained in a neutral state. Conventionally conducted chemotherapy was capable of beating the slow-spreading lymphoma types and keeping several patients in a state of remission. However, on every instant lymphomas recurred, they learnt abler means of surviving such lethal medications.
However, there have been noteworthy advancements of novel medications in the last decade.
Antibody Therapy
In the nineties, sanguinity was restored when scientists comprehended the manner in which to mass manufacture antibodies to combat a type of immune B-cell, known as monoclonal antibodies observed in ninety percent of the NHL cases. These monoclonal antibodies obliterated lymphoma cells by exploiting the capability of the immune system.
The Manner [...]
July 14th, 2010 |
Lymphoma
Latest Advancements in Non-Hodgkin Lymphoma Research
Studies conducted for probing the reasons, preclusion and therapy of NHL or non-Hodgkin lymphoma are on-going in several medical facilities across the globe.
Genetics
Researchers continue to make notable advancements in comprehending the genetics of non-Hodgkin lymphoma. They are gaining knowledge about the manner in which genes alter for causing uninhibited cell growth, lengthier existence and not maturing. This would thus assist them in creating medicines for blocking this process.
New-fangled tests for finding and classifying lymphoma are additionally being researched. Several of such tests could be capable of forecasting the manner in which the cancer would show response to chemotherapy, how totally the cancer could be obliterated by therapy or if there is a likelihood of the cancer coming [...]
July 12th, 2010 |
Lymphoma
Understanding Symptoms of Non-Hodgkins Lymphoma
Non-Hodgkins Lymphoma (or NHL or lymphoma) is a cancer starting in the lymphocytes cells (lymph nodes, lymphoid tissue like bone marrow, spleen) that are part of the body’s immune system. Lymphomas would originate in the lymphoid tissue and could then metastasize to the other body organs.
Non-Hodgkin lymphoma and Hodgkin lymphoma (other terms – Hodgkin’s disease or Hodgkin’s lymphoma) are duo key forms of lymphomas. The cellular appearances of such duo lymphoma forms differ microscopically. However in several scenarios, specialized laboratory tests might become necessary for differentiating them.
Inception and Metastasis of non-Hodgkins lymphoma
Non-Hodgkin lymphoma or NHL is mostly segregated on the basis of microscopic appearance of cancerous cells, particular characteristics of the [...]
July 7th, 2010 |
Lymphoma
